Detalhe da pesquisa
1.
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy.
Eur J Nucl Med Mol Imaging
; 51(6): 1516-1529, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267686
2.
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 51(8): 2428-2441, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528164
3.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
4.
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 51(1): 183-195, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721581
5.
The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.
BJU Int
; 130(3): 314-322, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674367
6.
Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 47(4): 907-921, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492995
7.
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial.
Eur J Nucl Med Mol Imaging
; 46(3): 728-742, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506283
8.
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF).
Eur J Nucl Med Mol Imaging
; 49(2): 424-426, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773165
9.
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study.
Eur J Nucl Med Mol Imaging
; 44(9): 1490-1500, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28361189
10.
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion.
Eur J Nucl Med Mol Imaging
; 40(12): 1853-60, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23864305
11.
Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT.
Clin Nucl Med
; 48(1): e12-e15, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240803
12.
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 39(1): 50-6, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21932117
13.
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.
Cancer Imaging
; 22(1): 67, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494731
14.
Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy.
EJNMMI Phys
; 9(1): 54, 2022 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976503
15.
Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.
J Neurol
; 269(7): 3579-3587, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103843
16.
PSMA Theranostics: Current Landscape and Future Outlook.
Cancers (Basel)
; 13(16)2021 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439177
17.
Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale.
Biomedicines
; 9(11)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34829796
18.
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells.
Cancers (Basel)
; 13(2)2021 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435224
19.
Quantitative SPECT (QSPECT) at high count rates with contemporary SPECT/CT systems.
EJNMMI Phys
; 8(1): 73, 2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718900
20.
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
J Nucl Med
; 62(7): 1006-1011, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127625